WOO Series
WOO SERIES - Patients perspectives on WOOs as a clinical research tool
November 2022
Summary
Why Patients should join WOOs – what do patients think of WOOs and research in general?
The WOO study design has increasingly become part of drug development. WOO trials exploit the ‘window’ of time after cancer diagnosis, typically prior to initiation of cancer therapy (usually surgery with curative intent). In presurgical WOO trials, patients with treatment naïve or early- stage disease are treated for a brief “window” period with a novel therapy followed by surgical resection. Unlike neoadjuvant trials, “window” period is kept short (a few weeks) to ensure the that surgery is not delayed.
Dr. Angel Arnaout MD MSC FRCSC MBA
Ottawa, Ontario, Canada
Co-Lead, Window of Opportunity Clinical Trials Program, Ontario Institute of Cancer Research, Professor of Surgery, University of Ottawa
Carol Gordon CPA, CFA
Ottawa, Ontario, Canada
Member, Patient & Family Advisory Council, Ontario Institute for Cancer Research
Comments (0)